Analyst Ratings for Krystal Biotech (KRYS)

KRYS Rating Summary

KRYS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KRYS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $112.50 (+86.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/18/2022 BofA Securities Alec Stranahan New Coverage Buy
(N/A)
110.00
(N/A)
62.28
(60.26)
-3.24% Details
7/20/2021 Goldman Sachs
» Updated 2/28/2022
Madhu Kumar Upgrade Buy
(Neutral)
93.00
(125.00)
61.09
(60.26)
-1.36% Details
Like KRYS Ratings? Also take a look at RCKT, RXDX, ISEE, TBIO

KRYS Ratings News